United Kingdom · Question · Written question
UIN 158929
Tixagevimab/cilgavimab
Original
Introduced
25 April 2022
Last action
28 April 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
28 April 2022
Summary
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 28 March 2022 to Question 141960 on Evusheld, when patients in the UK will have access to Evusheld as a preventative treatment for covid-19.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
25 April 2022
Written question
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 28 March 2022 to Question 141960 on Evusheld, when patients in the UK will have access to Evusheld as a preventative treatment for covid-19.
Source: Commons
28 April 2022
Answer
Any public announcement on the procurement of therapeutics would be made after an agreement is reached with companies, as this information is commercially sensitive. The Department continues to examine the potential introduction of prophylaxis, which incl...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-04-25/158929
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1459978
- uk · wq-1459978 · source updated 28 April 2022